Clinical Trials Sponsored by Global BioClinical

Total 1119 results

University of North Carolina, Chapel Hill
Global Dental Science, LLC

Withdrawn

Conventionally vs. Digitally Fabricated Complete Dentures: Clinical Treatment Outcome Differences

Mouth, Edentulous

United States
ALK-Abelló A/S
Ergomed; ACM Pivotal Global Central Laboratory

Completed

House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma (MITRA)

Asthma

Germany
The George Institute for Global Health, China
Chinese Diabetes Society

Completed

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Diabetes

China
University of Calgary
The George Institute for Global Health, Australia

Not yet recruiting

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 (ACT-WHEN)

Acute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke Acute

Canada, Australia
International Centre for Diarrhoeal Disease Research...
Global Affairs Canada

Recruiting

Nutri-CAP: Nutrition for Children, Adolescent Girls, and Pregnant Women in Slums of Dhaka City

Health Behavior | Gestational Weight Gain | Undernutrition | Diet, Food, and Nutrition

Bangladesh
Astellas Pharma Global Development, Inc.
Seagen Inc.

Active, not recruiting

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Bladder Cancer | Urothelial Cancer | Ureteral Cancer

United States, Japan, Korea, Republic of, Taiwan, Argentina, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, Switzerland, United Kingdom
Astellas Pharma Global Development, Inc.
Seagen Inc.

Completed

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

Metastatic Urothelial Cancer and Other Malignant Solid Tumors

United States, Canada
Ji Hye Yoon
COSMAX; Global medical research center

Completed

Evaluation of Human Efficacy for Skin Moisturization and Wrinkle Improvement

Dry Skin

Korea, Republic of
Astellas Pharma Global Development, Inc.
Seagen Inc.

Completed

ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer

Metastatic Urothelial Cancer

United States, Canada
Astellas Pharma Global Development, Inc.
Seagen Inc.

Approved for marketing

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

Locally Advanced or Metastatic Urothelial Carcinoma (UC)

United States
Piramal Healthcare Canada Ltd
Smith & Nephew, Inc.; Global Research Solutions

Terminated

Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions (RECORD)

Degenerative Lesion of Articular Cartilage of Knee | Traumatic; Lesion

Spain, France, Australia, Canada, Germany, Switzerland, United Kingdom
Johns Hopkins University
Global Fund; National Tuberculosis Control Program, Pakistan

Completed

A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes

Smoking Cessation | Tuberculosis

Pakistan
Astellas Pharma Global Development, Inc.
Medivation, Inc.

Terminated

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Metastatic Castration Resistant Prostate Cancer

United States
PepsiCo Global R&D
Food and Nutrition Research Institute, Philippines

Completed

Iron Bioavailability of Fortified Oat Drink

Iron Absorption

Philippines
Astellas Pharma Global Development, Inc.
Medivation, Inc.

Withdrawn

A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer
University Hospitals Cleveland Medical Center
Astellas Pharma Global Development, Inc.

Withdrawn

Alefacept in Kidney Transplant Recipients

Kidney Transplantation

United States
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation (PROMPT-AF)

Persistent Atrial Fibrillation | Catheter Ablation

China
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT)

Hypertension | Atrial Fibrillation

China
Global Healthy Living Foundation
University of Alabama at Birmingham; Illumination Health

Recruiting

The ArthritisPower Wearable Study (WEAR)

Rheumatoid Arthritis

United States
Philips Clinical & Medical Affairs Global
Pulmonary Critical Care Associates of Baltimore

Withdrawn

Sparkle Respiratory Effort Validation

Sleep Apnea, Obstructive | Sleep Apnea, Central

United States
Encube Ethicals Pvt. Ltd.
Novum Pharmaceutical Research Services; ACM Global Laboratories

Completed

Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis

Tinea Pedis

United States, Belize, Saint Lucia
University of Southern California
Bristol-Myers Squibb; Sanofi; Roche Global Development

Unknown

Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer

Gastric Cancer | Esophageal Cancer

United States
Universitätsmedizin Mannheim
Hector-Stiftung; humediQ global GmbH, Grünwald; Vitaphone GmbH, Mannheim

Completed

Telemonitoring of Geriatric Cancer Patients Using Handheld Devices

Cancer

Germany
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus (CANVAS-R)

Diabetes Mellitus, Type 2 | Albuminuria

Australia, France, Italy, Poland, Ukraine, United Kingdom, United States, China, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Malaysia, Canada, Netherlands, Korea, Republic of, New Zealand, Brazil, Russian Federation, Puerto... and more
Swiss Federal Institute of Technology
Global Alliance for Improved Nutrition; UNICEF

Withdrawn

RCT of Iodine-containing MNPs vs Oral Iodized Oil to Prevent Iodine Deficiency in Weaning Infants

Iodine Deficiency Disorders
Mahidol University
McLaughlin-Rotman Center for Global Health, University of Toronto

Completed

Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria

Falciparum Malaria

Thailand
Astellas Pharma Global Development, Inc.
Janssen Biotech, Inc.

Completed

A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects

Healthy Subjects | Bioavailability of ASP015K | Pharmacokinetics of ASP015K | Food Effect of ASP015K

United States
Globe Pharmaceuticals Limited
Globe pharmaceuticals Ltd, Dhaka, Bangladesh

Unknown

Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial

Axial Spondyloarthritis

Bangladesh
Quan Dong Nguyen
Oculis; Global Ophthalmic Research Center (GORC)

Recruiting

Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema (LEOPARD)

Uveitis Related Cystoid Macular Edema | Cystoid Macular Edema, Postoperative

United States
Vladimíra Dostálová
Barcelona Institute for Global Health

Recruiting

Testing a Nature-based Socila Intevention on Loneliness: the RECETAS-PRG Trial

Loneliness

Czechia
King's College London
Zoe Global Limited; Department of Health, United Kingdom

Recruiting

Testing the Accuracy of a Digital Test to Diagnose Covid-19

Covid-19

United Kingdom
Merck Sharp & Dohme LLC
Seagen Inc.; Astellas Pharma Global Development, Inc.

Active, not recruiting

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

Urinary Bladder Cancer, Muscle-invasive

Canada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
Philips Clinical & Medical Affairs Global
Pulmonary Critical Care Associates of Baltimore

Completed

DreamKit Respiratory Effort Signal Validation

Sleep Apnea, Obstructive | Sleep Apnea, Central

United States
Annexon, Inc.
International Centre for Diarrhoeal Disease Research, Bangladesh; ResearchPoint...

Completed

A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)

Guillain-Barré Syndrome

Denmark, Bangladesh
Douglas Pharmaceuticals America Ltd
Novum Pharmaceutical Research Services; ACM Global Laboratories

Completed

A Therapeutic Equivalence Study of Ketoconazole Cream 2%

Tinea Pedis

Belize, United States
Robert W Alexander, MD
Regeneris Medical; Global Alliance for Regenerative Medicine

Unknown

Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease (BRT)

Osteoarthritis | Back Pain | Tendinopathy | Tendinosis | Degenerative Joint Disease | Rheumatoid Nodule

United States
Astellas Pharma Global Development, Inc.
Janssen Biotech, Inc.

Completed

A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study

Arthritis, Rheumatoid

United States, Belgium, Bulgaria, Colombia, Czechia, Hungary, Mexico, Poland
The George Institute for Global Health, China
Peking University People's Hospital

Completed

Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population

Hypertension

China
Astellas Pharma Global Development, Inc.
Janssen Biotech, Inc.

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects

Healthy Volunteers | Pharmacokinetics of ASP015K

United States
Omico
Hoffmann-La Roche; The George Institute for Global Health, Australia

Recruiting

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients (MoST-TAP)

Solid Tumor, Adult

Australia
Centre de Recherche Médicale de Lambaréné
Global Health Innovative Technology Fund

Not yet recruiting

Pan-Malaria Transmission-Blocking Vaccine AnAPN1 (PamTBVac)

Malaria

Gabon
Etan Orgel
Astellas Pharma Global Development, Inc.

No longer available

Individual Patient Expanded Access Gilteritinib (ASP2215)

AML

United States
Hospital Universitari Vall d'Hebron Research Institute
Barcelona Institute for Global Health

Completed

Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR) (CATCOVID-AIR)

Covid19 | Corona Virus Infection | Acute Respiratory Failure

Spain
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE)

Diabetes Mellitus, Type 2 | Diabetic Nephropathy

United States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

CANVAS - CANagliflozin cardioVascular Assessment Study (CANVAS)

Cardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk Factors

United States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
Pennington Biomedical Research Center
PepsiCo Global R&D; Quaker Oats Company

Completed

The Effect of Oat Based Breakfast Cereals on Satiety and Food Intake

Food Intake | Satiety

United States
University of East Anglia
PepsiCo Global R&D; Quadram Institute Bioscience

Unknown

Innovation in Food Production Techniques to Improve Bioactive Content (ENRICH)

Bioavailability

United Kingdom
Astellas Pharma Global Development, Inc.
Cubist Pharmaceuticals LLC

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects

Healthy Subjects | Pharmacokinetics of Fidaxomicin

United States
Astellas Pharma Global Development, Inc.
Janssen Biotech, Inc.

Completed

A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects

Healthy Subjects | Pharmacokinetics of ASP015K

United States
New York Obesity and Nutrition Research Center
PepsiCo Global R&D

Completed

Effect of Different Fiber Breakfasts on Appetite and Weight Change in Overweight Subjects

Obesity

Clinical Trials Sponsored by Global BioClinical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations